Video Latest - ecancer

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA

9 May 2019

Beyond second-line therapy: New hope for mCRC patients in Egypt

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

9 May 2019

Multi-target kinase inhibitors: From data to practice

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

9 May 2019

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

8 May 2019

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

8 May 2019

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

8 May 2019

Pharmacology update from ONS 2019

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

8 May 2019

Anti-cancer compound for brain cancer found in daffodils

Dr Lorenzo Caggiano - University of Bath, Bath, UK

2 May 2019

ALK-positive NSCLC: Treatments and latest developments

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong

29 Apr 2019

ALK-positive NSCLC: Current landscape

Dr Antonio Passaro and Prof Rafal Dziadziuszko

29 Apr 2019

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA

25 Apr 2019

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA

25 Apr 2019

Video